Introduction
THYROID NODULES
Over the past years, molecular diagnostics (MD) have become increasingly relevant in the preoperative workup of cytologically indeterminate (Bethesda III and IV) thyroid nodules (ITN).The leading molecular panels test for a wide range of molecular alterations and thereby ensure highly accurate rule-out and rule-in capabilities with test sensitivities ≥92% and specificities ≥38%.In this study, we compared the diagnostic performance of MD and [